Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS: JUNE ISSUE PUBLISHED
  • JUNE 2021 Issue has been successfully launched on 1 June 2021.

Abstract

STUDY ON THE SAFETY, EFFICACY AND TOLERABILITY OF GLICLAZIDE & GLIMEPIRIDE IN TYPE 2 DIABETES MELLITUS PATIENTS

*Dr. M. Jamuna Rani and Dr. Somnath Motgi

ABSTRACT

Background: Type II diabetes mellitus is the chronic metabolic disorder .Gliclazide modified release and Glimepiride are the two sulphonylurea drugs used most frequently in type 2 diabetes treatment. Aim of the study: To study the safety, efficacy and tolerability of Gliclazide & Glimepiride in type 2 diabetes mellitus. Materials and Methods: Prospective observational study done on 50 patients who were on both Gliclazide and Glimiperide in the department of Pharmacology . Mallareddy Institute of Medical Sciences, Hyderabad, Telangana for 6 months duration ie, between February 2020 to July 2020. Results: Majority of the patients were in the age group 41-50 years ie, 42% (21/50), Followed by 22% (11/50),. Male: Female ratio -0.7:125 .Patients treated with gliclazide did not show any adverse drug reaction. 12 patients with glimepiride showed adverse drug reactions. The HbA1c levels were found to be reduced significantly in patients treated with gliclazide. Conlcusion: Gliclazide showed reduction in fasting blood sugar, 2h-Post prandial blood sugar and HbA1c.

Keywords: Gliclazide, Glimepiride.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More